YCBD
YCBD
AMEX · Pharmaceuticals

Cbdmd Inc

$0.43
-0.02 (-3.44%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +6,324.3% upside
Low Target $15.39
Average Target $27.92
High Target $30.56
Current Price $0.43
Current
$0.43
Target
$27.92
$15.39 $27.92 avg $30.56
Scenario Analysis
Bear Case
$15.39
3,441.2%
Low target
Base Case
$27.92
+6,324.3%
Avg target
Bull Case
$30.56
+6,931.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.56
-83.0% from high
52-Week Low
$0.45
+-3.9% from low
Target vs 52W High
$27.92
+990.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%